Page last updated: 2024-08-21

malondialdehyde and Huntington Disease

malondialdehyde has been researched along with Huntington Disease in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (44.44)29.6817
2010's3 (33.33)24.3611
2020's2 (22.22)2.80

Authors

AuthorsStudies
Feligioni, M; Fotoohi, A; Hassanzadeh, K; Hosseini, S; Izadpanah, E; Moloudi, MR1
Abdel Moneim, AE; Abdelfattah, MS; Aref, AM; Attia, GH; Badr, SEA; Kassab, RB; Lotfy, SA1
Kalia, AN; Kaur, M; Prakash, A1
Borrero-Sánchez, J; Cabrera-Rivero, A; Castillo-Casañas, Y; Esteban-Hernández, EM; Fernández-Almirall, I; Fernández-Carriera, R; González-García, S; González-Quevedo, A; Guerra-Badía, R; Hernández-Díaz, Z; Lara-Fernández, G; Martínez-Bonne, O; Menéndez-Sainz, MC; Peña-Sánchez, M; Pérez-López, C; Riverón-Forment, G; Soto-Lavastida, A; Valdés-Ramos, L; Zaldívar-Vaillant, T1
Beal, MF; Calingasan, NY; Cormier, K; Ferrante, RJ; Smith, K; Wille, EJ; Yang, L1
Galván-Arzate, S; Maldonado, PD; Molina-Jijón, E; Pedraza-Chaverrí, J; Santamaría, A; Villeda-Hernández, J1
Christofides, J; Darlington, LG; Egerton, M; Forrest, CM; Mackay, GM; Stone, TW; Stoy, N1
Chen, CM; Cheng, ML; Chiu, DT; Lee, PW; Lee, YM; Liu, JL; Soong, BW; Wu, YR1
Alam, ZI; Halliwell, B; Jenner, P1

Other Studies

9 other study(ies) available for malondialdehyde and Huntington Disease

ArticleYear
A Novel Pharmacological Protective Role for Safranal in an Animal Model of Huntington's Disease.
    Neurochemical research, 2021, Volume: 46, Issue:6

    Topics: Animals; Antioxidants; Behavior, Animal; Body Weight; Catalase; Cerebral Cortex; Cyclohexenes; Glutathione; Huntington Disease; Locomotion; Male; Malondialdehyde; Mastication; Neuroprotective Agents; Nitro Compounds; Propionates; Rats, Wistar; Rotarod Performance Test; Superoxide Dismutase; Terpenes

2021
Rutin and Selenium Co-administration Reverse 3-Nitropropionic Acid-Induced Neurochemical and Molecular Impairments in a Mouse Model of Huntington's Disease.
    Neurotoxicity research, 2020, Volume: 37, Issue:1

    Topics: Animals; bcl-2-Associated X Protein; Brain-Derived Neurotrophic Factor; Caspase 3; Catalase; Corpus Striatum; Down-Regulation; Drug Synergism; Glial Fibrillary Acidic Protein; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Huntington Disease; Interleukin-1beta; Male; Malondialdehyde; Mice; Neuroprotective Agents; Nitric Oxide; Nitro Compounds; Oxidative Stress; Peroxidase; Propionates; Proto-Oncogene Proteins c-bcl-2; Rutin; Selenium; Superoxide Dismutase; Synaptic Transmission; Tumor Necrosis Factor-alpha; Up-Regulation

2020
Neuroprotective potential of antioxidant potent fractions from Convolvulus pluricaulis Chois. in 3-nitropropionic acid challenged rats.
    Nutritional neuroscience, 2016, Volume: 19, Issue:2

    Topics: Animals; Antioxidants; Behavior, Animal; Body Weight; Convolvulus; Corpus Striatum; Glutathione; Huntington Disease; Lipid Peroxidation; Male; Malondialdehyde; Neuroprotective Agents; Neurotoxicity Syndromes; Nitrites; Nitro Compounds; Propionates; Rats; Rats, Wistar; Superoxide Dismutase

2016
Association of status redox with demographic, clinical and imaging parameters in patients with Huntington's disease.
    Clinical biochemistry, 2015, Volume: 48, Issue:18

    Topics: Adult; Age Factors; Age of Onset; Aged; Antioxidants; Biomarkers; Case-Control Studies; Catalase; Caudate Nucleus; Female; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Glycation End Products, Advanced; Humans; Huntington Disease; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Oxidative Stress; Sulfhydryl Compounds; Superoxide Dismutase; Tomography, X-Ray Computed

2015
Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases.
    Journal of neurochemistry, 2009, Volume: 109, Issue:5

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 8-Hydroxy-2'-Deoxyguanosine; alpha-Synuclein; Analysis of Variance; Animals; Chromatography, High Pressure Liquid; Creatine; Deoxyguanosine; Disease Models, Animal; Dopamine; Drug Therapy, Combination; Glutathione; Glutathione Disulfide; Huntington Disease; Lipid Peroxidation; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Nitro Compounds; Parkinson Disease; Propionates; Rats; Rats, Inbred Lew; Tyrosine 3-Monooxygenase; Ubiquinone

2009
NAD(P)H oxidase contributes to neurotoxicity in an excitotoxic/prooxidant model of Huntington's disease in rats: protective role of apocynin.
    Journal of neuroscience research, 2010, Feb-15, Volume: 88, Issue:3

    Topics: Acetophenones; Animals; Corpus Striatum; Disease Models, Animal; Huntington Disease; Lipid Peroxidation; Male; Malondialdehyde; Motor Activity; NADPH Oxidases; Neuroprotective Agents; Nitric Oxide Synthase; Protein Carbonylation; Quinolinic Acid; Rats; Rats, Wistar; Superoxides; Time Factors; Xanthine Oxidase

2010
Tryptophan metabolism and oxidative stress in patients with Huntington's disease.
    Journal of neurochemistry, 2005, Volume: 93, Issue:3

    Topics: Adolescent; Adult; Aged; Aldehydes; Brain; Female; Humans; Huntington Disease; Kynurenine; Male; Malondialdehyde; Middle Aged; Neopterin; Nerve Growth Factors; Oxidative Stress; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Tryptophan

2005
Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington's disease patients.
    Biochemical and biophysical research communications, 2007, Jul-27, Volume: 359, Issue:2

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Aged; Biomarkers; Deoxyguanosine; DNA, Mitochondrial; Erythrocytes; Female; Humans; Huntington Disease; Male; Malondialdehyde; Middle Aged; Mitochondria; Oxidative Stress; Superoxide Dismutase

2007
No evidence for increased oxidative damage to lipids, proteins, or DNA in Huntington's disease.
    Journal of neurochemistry, 2000, Volume: 75, Issue:2

    Topics: Adult; Aged; Brain; Caudate Nucleus; DNA; Female; Frontal Lobe; Gas Chromatography-Mass Spectrometry; Humans; Huntington Disease; Lipid Metabolism; Male; Malondialdehyde; Middle Aged; Nerve Tissue Proteins; Oxidative Stress; Putamen; Reference Values; Thiobarbituric Acid Reactive Substances

2000